Results 221 to 230 of about 82,001 (268)

Evaluation of confirmatory data following the Article 12 MRL review for isoxaben

EFSA Journal, Volume 24, Issue 5, May 2026.
Abstract The applicant Corteva Agriscience International Sàrl submitted a request to the competent national authority in Sweden to evaluate the confirmatory data that were identified for isoxaben in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available.
European Food Safety Authority (EFSA), Giulia Bellisai, Giovanni Bernasconi, Luis Carrasco Cabrera, Irene Castellan, Monica del Aguila, Lucien Ferreira, Luna Greco, Renata Leuschner, Andrea Mioč, Stefanie Nave, Hermine Reich, Silvia Ruocco, Alessia Pia Scarlato, Marta Szot, Anne Theobald, Manuela Tiramani, Alessia Verani, Elena Zioga   +18 more
wiley   +1 more source

CSPG4 Mediates Inflammatory, Cell Death, and Senescence Responses in Enteric Glia Exposed to Clostridioides difficile Toxins

The FASEB Journal, Volume 40, Issue 8, 30 April 2026.
Enteric glia in humans, mice, and rats express all known receptors for TcdA (LDLR) and TcdB (CSPG4, FZD‐1, FZD2, FZD7, PVRL3, TFPI, LRP1). CSPG4 expression is increased in colonic tissues from humans and mice with C. difficile infection, as well as in rat enteric glia exposed to TcdA or TcdB. C.
Francisco M. S. Marques, Deiziane V. S. Costa, Conceição S. M. Rebouças, Gerly A. C. Brito, Cirle A. Warren, Renata F. C. Leitão   +5 more
wiley   +1 more source

Spectral-Domain Optical Coherence Tomography-Driven Treat-and-Extend and Pro Re Nata Regimen in Patients with Macular Oedema due to Retinal Vein Occlusion: 24-Month Evaluation and Outcome Predictors.

Ophthalmic Res, 2018
Guichard MM, Xavier AR, Türksever C, Pruente C, Hatz K.   +4 more
europepmc   +1 more source

Fibrosis in Patients With Choroidal Neovascularization Based on Spectral-Domain Optical Coherence Tomography: Findings From the HARBOR Trial. [PDF]

J Vitreoretin Dis
Adrean SD, Hill L, Amador-Patarroyo J.
europepmc   +1 more source

Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United Kingdom. [PDF]

J Mark Access Health Policy
Lorenzi M, Ebohon S, Kissner J, Comiskey J, Paap M, Bouchet C, Garnham A, Wissinger E.   +7 more
europepmc   +1 more source

Patient participation in pro re nata medication in forensic psychiatric inpatient care

, 2021
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Children’s postoperative pro re nata (PRN) analgesia: Nurses’ administration practices

Contemporary Nurse, 2011
This paper reports a study aimed at exploring the nursing practices associated with the administration of pro re nata (PRN) postoperative analgesia to children, and at gaining a preliminary understanding of the decisions that nurses make about this important intervention.Nurses are responsible for assessing and administering the appropriate medication ...
Smyth, Wendy, Toombes, Janelle, Usher, Kim   +2 more
openaire   +4 more sources

Pro Re Nata Medication for Psychiatric Inpatients: Time to Act

Australian & New Zealand Journal of Psychiatry, 2008
Pro re nata (PRN; ‘as needed’) medication is an archetypal mainstay for managing acute psychiatric inpatient symptoms and behaviours. Psychiatric and mental health nursing practices have circumnavigated the development of a uniform medical–ethical standard for the administration of PRN psychotropic medication.
Michael Hilton, Whiteford, Harvey
openaire   +5 more sources

Use of Pro Re Nata Medications in Acute Inpatient Care

Australian & New Zealand Journal of Psychiatry, 2008
Objectives: Available evidence suggests that the use of ‘as needed’ (PRN; from the Latin pro re nata: for an occasion that has arisen) medications has remained a standard aspect of treatment in acute inpatient mental health units over a number of years despite lack of evidence from controlled clinical trials.
Jane, Stein-Parbury, Kim, Reid, Narelle, Smith, Diane, Mouhanna, Fiona, Lamont   +4 more
openaire   +4 more sources

Scheduled versus Pro Re Nata Dosing in the VIEW Trials

Ophthalmology, 2015
To analyze visual acuity (VA) outcomes before and after preplanned treatment regimen change in the VIEW studies at week 52 (W52).Multiple post hoc analyses for retrospectively defined subgroups in 2 multicenter, multinational, double-masked trials.Two thousand four hundred fifty-seven neovascular age-related macular degeneration (AMD) patients.Patients
Gisbert, Richard, Jordi, Monés, Sebastian, Wolf, Jean François, Korobelnik, Robyn, Guymer, Michaella, Goldstein, Christiane, Norenberg, Rupert, Sandbrink, Oliver, Zeitz   +8 more
openaire   +4 more sources